Understanding Ebola: Professor explains how disease works and how to make headway against it

by Alvin Powell
"The disease spreads through very close personal contact, blood and feces. It is not transmitted by respiratory droplets like influenza [is]," explained Harvard Humanitarian Initiative Director Michael VanRooyen (left). "I would agree with the CDC that the risk of an epidemic spreading in the United States is very low." Credit: Justin Ide

Though a few Ebola-infected Americans have begun returning home from the epidemic in West Africa, U.S. medical experts believe that there is still little risk that the epidemic will gain hold here. Key questions, however, include how much help U.S. organizations will give to overwhelmed medical facilities in affected nations, and how quickly personnel there can get the disease under control.

To better understand the disease and the threat it presents, the Gazette spoke with Michael VanRooyen, director of the Harvard Humanitarian Initiative (HHI), which works to improve humanitarian response to disasters around the world through training, research, and by developing tools that put information at responders' fingertips.

VanRooyen, a professor at Harvard Medical School and the Harvard School of Public Health and vice chairman of Harvard-affiliated Brigham and Women's Hospital's Department of Emergency Medicine, has extensive experience responding to humanitarian crises, from the Rwandan genocide to the turmoil in the eastern Democratic Republic of the Congo to the 2010 Haiti earthquake, when HHI and physicians from Harvard-affiliated hospitals erected a field hospital to handle the injured. Here are his thoughts.

GAZETTE: What's the most important thing for the American public to understand about this outbreak?

VANROOYEN: I think most important is that there's no cause for panic. We have experts who understand the spread of this virus and how to protect the public from it. When the [nonprofit] Samaritan's Purse, for example, evacuates somebody and has them sent to Atlanta for treatment and surveillance, it does not pose an epidemic risk in the United States. That's probably first and most important.

Second, the countries that we work in, like Sierra Leone and Liberia and Guinea, depend on us to lead the response. This epidemic has rapidly exceeded the capacity of local hospitals and health institutions, and we should mobilize resources to help. We have well-trained experts and significant resources to provide a robust response by the CDC [Centers for Disease Control and Prevention], as well as NGOs [nongovernmental organizations], and even the private sector. We need to quickly mobilize people to help control the epidemic and undertake a .

GAZETTE: What are the biggest medical needs?

VANROOYEN: We have close colleagues working in Liberia and Sierra Leone, and they have indicated two major areas of need.

First is greater technical support of the health care delivery program for better hospital treatment, case management, and quarantine. Some of the hospitals in Liberia are closing down or severely reducing their capacity because they don't have gowns, gloves, respirators, or other protective gear. One critical essential need is the personal protective gear that will allow front-line to safely treat infected patients. Linked with that is medical expertise: It is essential to send physicians, nurses, and public-health experts who have significant expertise and some prior experience with acute onset epidemics. The right people and supplies can go a long way in stemming the spread of the disease.

The second area that we really need to enhance is community education. The virus spreads from person to person through intimate contact, such as feces and blood and preparing bodies for burial. This puts health care workers, close family members, and those preparing the dead for burial at risk. Although there has been an aggressive campaign in recent years, in some places, like Sierra Leone and Liberia, it's [backfired and] actually caused people to be suspicious of health care workers.

GAZETTE: We're hearing that the disease is hard to spread and not a big danger to the U.S., and yet it does seem to be spreading in Africa. Why it isn't considered a danger here?

VANROOYEN: The disease spreads—and the CDC has confirmed this—through very close personal contact, blood and feces. It is not transmitted by respiratory droplets like influenza [is]. As long as people are under proper care and appropriate precautions are taken, there's no reason to think we can't control the transmission of the virus. So in that sense, it's not like SARS [severe acute respiratory syndrome] or MERS [Middle East respiratory syndrome], for example, where we would worry about an epidemic spreading in the United States.

GAZETTE: Because SARS is respiratory?

VANROOYEN: Exactly. With SARS or influenza, the disease can spread through casual contact, such as on a bus, train, or plane. But fortunately, Ebola is only spread by patients who have become symptomatic, and then only spread through close contact with blood, feces, and other bodily fluids. If you have no symptoms, you don't spread the illness. If we are carefully screening patients who have been exposed to Ebola and become ill, the transmission can be controlled. I would agree with the CDC that the risk of an epidemic spreading in the United States is very low.

GAZETTE: What has your involvement been so far?

VANROOYEN: The strongest [personal] connection I have is that I used to work pretty closely with Samaritan's Purse and other NGOs working at the epicenter of the Ebola outbreak. In particular, I have been helping them advise their medical staff who have returned to the U.S. after working in the hot zone to determine if and how long they should be quarantined, and where they should go if they became ill.

Recently we've been approached by the American Red Cross and the International Rescue Committee to deploy emergency physicians to help run the health programs for the epidemic response. We are discussing this with a few of our experienced international physicians, but have not decided to send them yet. We are in close consultation with colleagues from Brigham and Women's Hospital to help decide under what circumstances it is safe to send them.

GAZETTE: So it would be a Harvard person associated with HHI working for one of these NGOs?

VANROOYEN: All clinical relief work we do is through our partner hospitals. Although these physicians are academically affiliated with HHI, they are performing clinical work as a hospital physician from the Brigham or other Harvard-affiliated hospital.

GAZETTE: Is there a particular specialty they're looking for?

VANROOYEN: They're primarily looking for emergency-medicine physicians with relief experience, although in this case infectious disease specialists and those with experience managing an epidemic would be most helpful. Although we have a group of emergency physicians that have had specialty training in humanitarian medicine, few have experience in managing an epidemic.

GAZETTE: They have experience overseas and in crisis situations?

VANROOYEN: Yes. Most have specific training in humanitarian assistance as well as significant experience with multiple deployments in refugee health settings in conflict and disasters. Obviously, the Ebola epidemic is unique and requires a specific training.

GAZETTE: What's the role of an academic institution like Harvard and our affiliated hospitals, and what should it be in this sort of a situation?

VANROOYEN: In general, the role of an academic institution is not to provide clinical services on the ground in an epidemic, but to provide other types of support for NGOs, through research and information management. Although we may send hospital medical staff to work in medical facilities, the role of Harvard is to investigate and address the broader implications of the epidemic, such as the social and political implications of this epidemic in Sierra Leone, which already has an unstable government. There are significant collateral issues that can lead to political instability and public mistrust of the government.

We also provide better data collection tools for organizations to gather and share data real-time. Organizations responding to these crises may not place a priority on data collection, management, analysis, and sharing, and we have worked in both Sierra Leone and Liberia in mapping population needs and disease patterns. As with other around the world, HHI and Harvard can play an important role in educating responders, understanding social, political, and human rights dimensions, and helping to optimize future responses.

add to favorites email to friend print save as pdf

Related Stories

Peace Corps withdraws from W. Africa over Ebola fears

Jul 31, 2014

The US Peace Corps announced Wednesday it was pulling hundreds of volunteers from Guinea, Liberia and Sierra Leone due to growing concerns over the spread of the deadly Ebola epidemic raging in West Africa.

Avoid Ebola panic and fear: UN chief

Aug 12, 2014

Urging governments to avoid panic and fear, UN chief Ban Ki-moon announced plans on Tuesday to step up the global response to the Ebola outbreak and bring it under control.

WHO holds emergency Ebola meeting

Aug 06, 2014

The World Health Organization on Wednesday began a two-day emergency meeting on west Africa's Ebola epidemic, with the UN agency deciding whether to declare it an international crisis.

Recommended for you

Syria hit by flesh-eating maggot disease

11 hours ago

Three cases of myiasis have been reported near Damascus, marking the first appearance of the flesh-eating maggot disease in Syria, UN health experts said Friday.

Sperm can carry Ebola for 82 days: WHO

12 hours ago

Sperm can carry the Ebola virus for at least 82 days, the World Health Organization said Friday, urging men recovering from the disease to use condoms for three months after the onset of symptoms.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.